This activity is supported by educational grants from AstraZeneca LP, Merck Sharp & Dohme, and Novo Nordisk, Inc.

Advancing the Management of Diabetes: An Update on New Guidelines and Treatment Options

Samuel L. Ellis, PharmD, BCPS

Associate Professor

Skaggs School of Pharmacy and Pharmaceutical Sciences

Aurora, Colorado

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose.

Faculty

Samuel L. Ellis, PharmD, BCPS

Pharmacy Times Office of Continuing Professional Education

Planning Staff—David Heckard; Maryjo Dixon, RPh; Donna Fausak; and Nathalie Harden

Pharmacy Times Editorial Staff

Bea Riemschneider and Kirk McKay

An anonymous peer reviewer was part of the content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Objectives

At the conclusion of this educational activity, participants should be able to:

• Discuss current management of type 2 diabetes mellitus (T2DM), including updated clinical practice guidelines and the incorporation of new therapeutic classes into practice recommendations.
• Identify and develop strategies that address clinical inertia and other barriers to optimal management of T2DM.
• Summarize how the pharmacist’s role is evolving and identify methods to improve diabetes management.

Target Audience: Pharmacists

Type of activity: Knowledge

Release date: May 9, 2014

Expiration date: May 9, 2016

Estimated time to complete activity: 1.5 hours

Fee: Free

Click here to view this activity.

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-14-045-H01-P. The activity is available for CE credit through May 9, 2016.